Delivery Order SPE2DB20D7061-SPE2DB25FSPC2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This firm fixed-price contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $696.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562142795 RHOGAM ULTRA-FILTERED PLUS SYRS. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from September 12, 2023 through October 3, 2023. The Defense Logistics Agency is a combat logistics support agency within the Department of Defense...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $1,180.20, is for the supply of Rho(D) Immune Globulin (Human) - RhoGAM Ultra-Filtered Plus Syringes, a specialty pharmaceutical product used to prevent Rh immunization. The contract is a firm fixed price delivery order with an ultimate completion date of April...
- This is a $2,360.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through December 10, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at approximately $928 under the Defense Logistics Agency's prime vendor contract to provide RHOGAM ULTRA-FILTERED PLUS syringes. The firm fixed price order calls for delivery to a location in Conshohocken, Pennsylvania by September 7, 2023 to support the Defense Logistics Agency's medical supply needs. Funding is provided by the Department of Defense with no set aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS. The contract has a firm fixed price and a ceiling value of $1,364.39. It is not set aside for any specific business type. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, is a major supplier of pharmaceutical and medical products to various federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,731.80, is a Firm Fixed Price Delivery Order for the supply of Rhogam Ultra-Filtered Plus Syrs, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rhogam Ultra-Filtered Plus Syringes, a specialty pharmaceutical product, with a ceiling value of $1,652.28. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and the ultimate completion date is November 13, 2024. This award is not designated as a set-aside...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The delivery order has a ceiling value of $1,969.36 and is a firm fixed price contract. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price ceiling value of $2,360.40 and an ultimate completion date of September 20, 2024. The contract is not a set-aside award. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPC2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of medications, vaccines, and medical supplies. This delivery order for RhoGAM, an immunoglobulin product used for RhD-negative pregnant women and patients, exemplifies the company's role in supplying specialized medical commodities to support defense healthcare operations. The contract carries no set-aside designation and was awarded through open competition, demonstrating the contractor's capability to meet federal procurement standards across its diverse medical supply offerings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/1/25 |